{
  "id": "cluster_28_doc3",
  "content": "The Neurocognitive Advancements Study (NL-TMS-455) at Yale-New Haven Hospital seeks participants aged 30-50 with post-thrombotic aphasia. Participants receive customized TMS regimens while insurers debate coverage under new neurological policy frameworks. Principal Investigator: Dr. Rajiv Mehta, r.mehta@yalenhn.org.",
  "metadata": {
    "format": "research_note"
  }
}